355 Results for "

Domain B

" in MedChemExpress (MCE) Product Catalog:
Products (355)

355 Results for "Domain B" in MCE Product Catalog:

Cat. No.: HY-115671
Purity:  99.99%
Target:  

Phosphatase

Research Areas:  

Neurological Disease

KLH45b is an inhibitor of DDHD2 (DDHD domain containing 2) .
loading...
    loading...
Cat. No.: HY-P99487
CAS No.: 869881-54-9
Synonyms: BR 3FC

Target:  

ADC Antibodies

Research Areas:  

Inflammation/Immunology

Briobacept (BR 3FC) is a recombinant glucoprotein, consists of 2 molecules from the BLyS receptor (BR3)and a Fc domain of human IgG1. Briobacept selectively targets to BLyS (BAFF), induces B cells apoptosis. Briobacept can be used in studies of rheumatoid arthritis (RA) .
loading...
    loading...
Cat. No.: HY-122735
CAS No.: 690216-38-7
Research Areas:  

Infection

Inh2-B1 is a Ser/Thr protein kinase (STK1) inhibitor. Inh2-B1 specifically inhibits STK1 activity by directly binding to its ATP-binding catalytic domain. Inh2-B1 down-regulates cell wall hydrolase genes and disrupts the biofilm formation of Methicillin-resistant Staphylococcus aureus (MRSA) clearly .
loading...
    loading...
Cat. No.: HY-P10550
Target:  

VEGFR

Research Areas:  

Cancer

VGB4 is a VEGF-A and VEGF-B antagonist peptide that duplicates two binding domains of VEGF-B (loop 1 and loop3) and are linked together by the receptor-binding domain of VEGF-A (loop3). VGB4 has significant anti-angiogenic and anti-tumor activities and can regulate tumor growth and metastasis through multiple mechanisms. VGB4 could be used in anti-tumor research .
loading...
    loading...
Cat. No.: HY-P991779

Target:  

EGFR

Research Areas:  

Cancer

Anti-Mouse/Human/Canine HER2 (domain III) Antibody (H2Mab-19) reacts with domain III of human and canine HER2. Anti-Mouse/Human/Canine HER2 (domain III) Antibody (H2Mab-19) exerts antitumor activity in mouse oral cancer xenografts. Recommend Isotype Controls: Mouse IgG2b kappa, Isotype Control (HY-P99982) .
loading...
    loading...
Cat. No.: HY-P991680
CAS No.: 3037408-21-9

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

Elipunercept is a fusion protein that combines human TNFRSF1B extracellular domain fragment (1-235) fused at the C-terminus to a human IgG1 Fc fragment. Elipunercept is an immunomodulator .
loading...
    loading...
Cat. No.: HY-W012248
CAS No.: 349-58-6
Target:  

FGFR

Research Areas:  

Cancer

KG-655 is a ligand that specifically binds to the ARNT PAS-B domain. KG-655 binds to the internal cavity of ARNT PAS-B to restrict its variable folded conformation, disrupts the interaction between ARNT PAS-B and the transcriptional coactivator TACC3, and promotes the homodimerization of ARNT PAS-B. KG-655 is widely applicable to cancer-related research .
loading...
    loading...
Cat. No.: HY-177756
CAS No.: 2230406-60-5
Target:  

BCL6

Research Areas:  

Cancer

BCL6-IN-11 is a potent inhibitor of the BCL6 BTB domain and a partial degrader of BCL6. BCL6-IN-11 inhibits the interaction between the BCL6 BTB domain and BCOR with an IC50 of 6 nM. BCL6-IN-11 can be used for research related to BCL6 degradation in diffuse large B-cell lymphoma (DLBCL) .
loading...
    loading...
Cat. No.: HY-P991092
Target:  

EGFR CD276/B7-H3

Research Areas:  

Cancer

IBI-334 is a bispecific B7-H3 and EGFR antibody. IBI-334 has an EGFR arm for signal blockage and is coupled with a fine-tuned B7-H3 arm with optimal affinity and binding domain. IBI-334 shows antibody-mediated cell cytotoxicity (ADCC) effects. IBI-334 has a wide range of applications in many EGFR-driven solid tumors .
loading...
    loading...
Cat. No.: HY-P5330
CAS No.: 505070-10-0
Target:  

NADPH Oxidase

Research Areas:  

Others

Noxa B BH3 is a biological active peptide. (BH3 domain of Noxa protein)
loading...
    loading...
Cat. No.: HY-170674
Research Areas:  

Cancer

ND-L11B is a potent degrader of nuclear receptor binding SET domain protein 2 (NSD2) and RE-IIBP, with the DC50 of 1.48 and 0.8 μM, the Dmax is closed to 80 % .
loading...
    loading...
Cat. No.: HY-170674A
Research Areas:  

Cancer

ND-L11B TFA is a potent degrader of nuclear receptor binding SET domain protein 2 (NSD2) and RE-IIBP, with the DC50 of 1.48 and 0.8 μM, the Dmax is closed to 80 % .
loading...
    loading...
Cat. No.: HY-148384A
CAS No.: 2925647-93-2
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

UHMCP1 dihydrochloride is a potent UHM domain splicing inhibitor with a Kd value of 79 μM. UHMCP1 dihydrochloride prevents the SF3b155/U2AF 65 interaction. UHMCP1 dihydrochloride impacts cell viability and RNA splicing .
loading...
    loading...
Cat. No.: HY-P5947
Target:  

HIV

Research Areas:  

Neurological Disease

Tat-HA-NR2B9 contains a fragment of the cellmembrane transduction domain of HIV-1 Tat, a influenza virus hemagglutinin (HA) epitope-tag, and the C-terminal 9 amino acids of NR2B (NR2B9c). Tat-HA-NR2B9 reduces infarct size and improves neurological functions in ischemia-induced cerebral injury in the rats
loading...
    loading...
Cat. No.: HY-161732
CAS No.: 2982663-28-3
Target:  

Bcl-2 Family

Research Areas:  

Cancer

GQN-B37-E is a potent selective binder and inhibitor of MCL-1. GQN-B37-E binds to the BH3-domain-binding pocket in MCL-1. GQN-B37-E exhibits binding affinity for MCL-1 at the submicromolar range (Ki = 0.6 μM) without apparent binding to BCL-2 or BCL-XL .
loading...
    loading...
Cat. No.: HY-B0563BS
CAS No.: 1217667-10-1
Ropivacaine-d7 hydrochloride is a deuterium labeled Ropivacaine (hydrochloride) (HY-B0563B) . Ropivacaine hydrochloride is a potent sodium channel blocker and blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibrese . Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane . Ropivacaine is widely used for neuropathic pain management in vivo .
loading...
    loading...
Cat. No.: HY-P990986
CAS No.: 2922216-49-5

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology Cancer

Efdelikofusp alfa is a bispecific Fc fusion protein. Efdelikofusp alfa is formed by fusing the N-terminal extracellular domain of human CD80 (B7.1) with the Fc fragment of human immunoglobulin G4 (IgG4), and is linked to an interleukin-2 variant (IL-2v) as the C-terminal part. Efdelikofusp alfa exhibits potential immunostimulatory, immune checkpoint inhibitory, and antitumor activities.
loading...
    loading...
Cat. No.: HY-P990992
CAS No.: 2922216-50-8
Synonyms: GI-102

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology Cancer

Efzilonkofusp alfa is a bispecific Fc fusion protein. Efzilonkofusp alfa is formed by fusing the N-terminal extracellular domain of human CD80 (B7.1) with the Fc fragment of human immunoglobulin G4 (IgG4), and is linked to an interleukin-2 variant (IL-2v) as the C-terminal part. Efzilonkofusp alfa exhibits potential immunostimulatory, immune checkpoint inhibitory, and antitumor activities.
loading...
    loading...
Cat. No.: HY-P71284
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SEMA4B; Semaphorin-4B; Prev. SEMAC; MGC131831; KIAA1745; Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) And Short Cytoplasmic Domain, 4B; SemC; SEMA4B Protein; Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) And Shor
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P78034
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: SEMA4B; Semaphorin-4B; Prev. SEMAC; MGC131831; KIAA1745; Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) And Short Cytoplasmic Domain, 4B; SemC; SEMA4B Protein; Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) And Shor
Species:  
Mouse
Source:  
HEK293
loading...
    loading...